Hereditary angioedema in pregnancy and management without recombinant human C1-INH
A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | Brasil |
| Institución: | Universidade Federal do Rio Grande do Sul (UFRGS) |
| Repositorio: | Repositório Institucional da UFRGS |
| Idioma: | inglés |
| OAI Identifier: | oai:www.lume.ufrgs.br:10183/233244 |
| Acceso en línea: | http://hdl.handle.net/10183/233244 |
| Access Level: | acceso abierto |
| Palabra clave: | Mulheres Gravidez Angioedemas hereditários Gravidez de alto risco Prevenção de doenças Hereditary angioedema HAE C1-inhibitor High-risk pregnancy Prophylaxis |
| Sumario: | A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-INH concentrate. |
|---|